Literature DB >> 22234484

Triggers for attacks in familial Mediterranean fever: application of the case-crossover design.

Gayane Yenokyan1, Haroutune K Armenian.   

Abstract

The etiology of recurrent attacks of serositis in familial Mediterranean fever (FMF) is not completely understood. Uncontrolled clinical case series have reported that factors associated with emotional, physiological, or physical stress precede and might trigger the attacks. This case-crossover study, conducted between July 2007 and May 2008, aimed to estimate the role of precipitating factors in attacks in a sample of Armenian FMF patients in Yerevan, Armenia, where 104 patients contributed 55 case and 189 control time periods. The authors used conditional logistic regression to compare frequency of exposure to stressful events, strenuous physical activity, menstrual periods, and high-fat food consumption prior to FMF attacks and on attack-free random days. Multiple stressful life events predicted FMF attacks 2 days following the event. After adjustment for treatment, an additional stressful event was associated with an estimated 70% increase in the odds of having an FMF attack on the second day (95% confidence interval: 1.04, 2.79). High levels of perceived stress were also associated with FMF attacks. Physical exertion and high-fat diet did not increase the likelihood of FMF attacks. The possibility of prevention of attacks in FMF needs to be tested through stress-reduction interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234484     DOI: 10.1093/aje/kwr460

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  PFAPA flares observed during COVID outbreak: can emotional stress trigger PFAPA attacks? A multicenter cohort study.

Authors:  Gil Amarilyo; Liora Harel; Yoel Levinsky; Yonatan Butbul Aviel; Sabreen Abu Ahmad; Mor Broide; Yulia Gendler; Neta Dagan; Michal Gafner; Hadar Gavra; Shelly Kagan; Kfir Kedar; Hamada Mohammad Natour; Rotem Tal; Tamar Veres
Journal:  Pediatr Rheumatol Online J       Date:  2022-07-08       Impact factor: 3.413

Review 2.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Xi Yin; Fangyuan Tian; Bin Wu; Ting Xu
Journal:  Cochrane Database Syst Rev       Date:  2022-03-29

3.  Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.

Authors:  Vildan Bostanci; Hulya Toker; Soner Senel; Omer Poyraz; Aysun Akpinar; Emine Pirim Görgün; Olcay Bakar
Journal:  Clin Oral Investig       Date:  2016-04-11       Impact factor: 3.573

4.  Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.

Authors:  Yasemin Bozkurt; Alper Demir; Burak Erman; Ahmet Gül
Journal:  Comput Math Methods Med       Date:  2015-05-28       Impact factor: 2.238

5.  The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever.

Authors:  Philip J Hashkes; Steven J Spalding; Rula Hajj-Ali; Edward H Giannini; Anne Johnson; Karyl S Barron; Michael H Weisman; Noune Pashinian; Andreas O Reiff; Jonathan Samuels; Dowain Wright; Daniel J Lovell; Bin Huang
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

6.  A Hypothesis Regarding Neurosecretory Inhibition of Stress Mediators by Colchicine in Preventing Stress-Induced Familial Mediterranean Fever Attacks.

Authors:  Cengiz Korkmaz; Döndü Üsküdar Cansu; Güven Barıs Cansu
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 7.  Interleukin-6 inhibition in the treatment of autoinflammatory diseases.

Authors:  Tomohiro Koga; Atsushi Kawakami
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

8.  Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome.

Authors:  Zhanna A Ktsoyan; Natalia V Beloborodova; Anahit M Sedrakyan; George A Osipov; Zaruhi A Khachatryan; Gayane P Manukyan; Karine A Arakelova; Alvard I Hovhannisyan; Arsen A Arakelyan; Karine A Ghazaryan; Magdalina K Zakaryan; Rustam I Aminov
Journal:  Front Cell Infect Microbiol       Date:  2013-01-28       Impact factor: 5.293

9.  Interventions for reducing inflammation in familial Mediterranean fever.

Authors:  Bin Wu; Ting Xu; Youping Li; Xi Yin
Journal:  Cochrane Database Syst Rev       Date:  2018-10-19

10.  Probiotic Lactobacillus acidophilus Strain INMIA 9602 Er 317/402 Administration Reduces the Numbers of Candida albicans and Abundance of Enterobacteria in the Gut Microbiota of Familial Mediterranean Fever Patients.

Authors:  Astghik Pepoyan; Marine Balayan; Anahit Manvelyan; Lilit Galstyan; Sofi Pepoyan; Susanna Petrosyan; Vardan Tsaturyan; Shigeru Kamiya; Tamas Torok; Michael Chikindas
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.